Technical Analysis for CPHI - China Pharma Holdings, Inc.

Grade Last Price % Change Price Change
grade F 0.2889 -2.40% -0.01
CPHI closed down 2.4 percent on Monday, May 20, 2019, on 23 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Flat Down Down
See historical CPHI trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Outside Day Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%

Older signals for CPHI ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. It offers products in the form of dry powder injectibles, liquid injectibles, tablets, capsules, oral solutions, and granules. The company's products are used for the treatment of central nervous system and cerebral cardiovascular, anti-infection and respiratory, and digestive and other diseases. Its products include Bumetanide to treat edema diseases; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Buflomedil Hydrochloride for blood vessel diseases; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and surgery-thrombus deep phlebitis; and Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and lipoprotein blood diseases. The company also provides Cefaclor Dispersible tablets for tympanitis, lower respiratory tract infection; Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Clarithromycin granules and capsules for nasopharynx, respiratory tract, and skin tissue infections; Naproxen Sodium and Pseudophedrine Hydrochloride Sustained Release tablets to relieve cold, sinus, and flu symptoms; Cefalexin capsules for acute tonsillitis; and Anhydroandrographolide for ischemic heart, cerebrovascular, and lipoprotein blood diseases. In addition, it offers Hepatocyte growth-promoting factor; Tiopronin; Omeprazole; Granisetron Hydrochloride injection; Vitamin B6; and Gull Wood extract syrup, as well as Recombined Human Fibroblast Growth Factor products for the repair of wounded skin cells. The company distributes its products through independent regional distributors and sales representatives. China Pharma Holdings, Inc. is based in Haikou, the People's Republic of China.
Medicine Chemistry Surgery Pharmacology Tablet
Is CPHI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.84
52 Week Low 0.19
Average Volume 877,261
200-Day Moving Average 0.2901
50-Day Moving Average 0.3438
20-Day Moving Average 0.3323
10-Day Moving Average 0.3212
Average True Range 0.0335
ADX 33.38
+DI 17.1612
-DI 15.3255
Chandelier Exit (Long, 3 ATRs ) 0.3095
Chandelier Exit (Short, 3 ATRs ) 0.3805
Upper Bollinger Band 0.368
Lower Bollinger Band 0.2966
Percent B (%b) -0.11
BandWidth 21.486609
MACD Line -0.0122
MACD Signal Line -0.0072
MACD Histogram -0.0051
Fundamentals Value
Market Cap 12.59 Million
Num Shares 43.6 Million
EPS -0.19
Price-to-Earnings (P/E) Ratio -1.50
Price-to-Sales 0.50
Price-to-Book 0.13
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.34
Resistance 3 (R3) 0.34 0.32 0.33
Resistance 2 (R2) 0.32 0.31 0.32 0.32
Resistance 1 (R1) 0.31 0.30 0.30 0.30 0.32
Pivot Point 0.29 0.29 0.29 0.29 0.29
Support 1 (S1) 0.28 0.28 0.27 0.27 0.26
Support 2 (S2) 0.26 0.27 0.26 0.25
Support 3 (S3) 0.24 0.26 0.25
Support 4 (S4) 0.24